Skip navigation
Skip navigation

Pharmacogenetic Impact of VKORC1 and CYP2C9 allelic variants on warfarin dose requirements in a hispanic population isolate

Palacio, LG; Falla, D.; Tobon, I; Mejia, F.; Lewis, J.E.; Martinez, A.F.; Arcos-Burgos, Mauricio (Oscar); Camargo, Mauricio

Description

Warfarin is the most prescribed oral anticoagulant worldwide. Because of the complexity of warfarin therapy, we attempted to dissect genetic from bioenvironmental factors influencing warfarin dose responses in individuals of a genetic isolate of Hispanic

CollectionsANU Research Publications
Date published: 2010
Type: Journal article
URI: http://hdl.handle.net/1885/79098
Source: Clinical and Applied Thrombosis/Hemostasis
DOI: 10.1177/1076029608330472

Download

File Description SizeFormat Image
01_Palacio_Pharmacogenetic_Impact_of_2010.pdf270.12 kBAdobe PDF    Request a copy


Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  12 November 2018/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator